Intrinsic Value of S&P & Nasdaq Contact Us

Omega Therapeutics, Inc. OMGA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+6211.4%

Omega Therapeutics, Inc. (OMGA) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 6 Buy, 1 Hold.

The consensus price target is $9.00 (low: $7.00, high: $11.00), representing an upside of 6211.4% from the current price $0.14.

OMGA Stock — 12-Month Price Forecast

$9.00
▲ +6,211.36% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Omega Therapeutics, Inc., the average price target is $9.00, with a high forecast of $11.00, and a low forecast of $7.00.
The average price target represents a +6,211.36% change from the last price of $0.14.
Highest Price Target
$11.00
Average Price Target
$9.00
Lowest Price Target
$7.00

OMGA Analyst Ratings

Buy
7
Ratings
6 Buy
1 Hold
Based on 7 analysts giving stock ratings to Omega Therapeutics, Inc. in the past 3 months
Rating breakdown
Buy
6 86%
Hold
1 14%
86%
Buy
6 analysts
14%
Hold
1 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message